ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
|---|---|---|---|---|
| Exploiting glypican diversity in neuroblastoma plasticity with bicistronic CAR T cell targeting | Children’s Hospital of Philadelphia / Kristopher Bosse, MD | 'A' Award Grants | 2022 | Pennsylvania |
| Epigenetic Enhancement of MHCI to Augment Neuroblastoma Immunotherapy | University of Wisconsin - Madison / Paul Sondel, MD, PhD and Amy Erbe-Gurel, PhD | Innovation Grants | 2022 | Wisconsin |
| Isoform-specific TNC-redirected T cell Therapy for DIPG | St. Jude Children’s Research Hospital / Stephen Gottschalk, MD and Giedre Krenciute, PhD | Innovation Grants | 2022 | Tennessee |
| GD2-directed CAR T cell therapy for H3K27M+ spinal cord diffuse midline glioma | Board of Trustees of the Leland Stanford Junior University / Michelle Monje | Catalyst Grants | 2021 | California |
| Redefining Osteosarcoma Metastases as Chronic Non-healing Lung Wounds: Implications for Developing Novel Therapies | Research Institute at Nationwide Children's Hospital / James Reinecke, MD/PhD | Young Investigator Grants | 2021 | Ohio |
| Activating Metabolic Pathways to Increase the Persistence of Leukemia Targeting T Cells | Children’s Hospital of Pittsburgh / Erica Braverman, MD | Young Investigator Grants | 2021 | Pennsylvania |
| Investigating Epigenetic Mechanisms of Response to Allogenic CAR T Cell Therapy | St. Jude Children’s Research Hospital / Caitlin Zebley, MD/PhD | Young Investigator Grants | 2021 | Tennessee |
| Dual PTK7/GD2 Gamma Delta CAR T Cell Therapy for Neuroblastoma | Emory University / Kelly Goldsmith, MD & H. Trent Spencer, PhD & Chris B. Doering, PhD | Reach Grants | 2021 | Georgia |
| In-vivo characterization of MYCN-driven immunosuppression | University of California San Francisco / William Weiss, MD/PhD | Innovation Grants | 2021 | California |
| High-throughput CAR NKT Library Screen for Improving Neuroblastoma Immunotherapy | Baylor College of Medicine / Xavier Rios, MD/PhD | Young Investigator Grants | 2020 | Texas |